Form D · Biotechnology
ELUTIA INC.
Silver Spring, MD · CIK 0001708527
Offering snapshot reported Oct 3, 2023 · SEC filing
- Reported sold
- $10.5M Offering amount: $10.5M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 21, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 3, 2023 | Initial | $10,500,000 | No comparison | 12 | SEC filing |
| Dec 22, 2021 | Initial | $13,999,975 | No comparison | 15 | SEC filing |
| Sep 14, 2020 | Initial | $5,039,427 | No comparison | 5 | SEC filing |
| Dec 18, 2019 | Initial | $3,050,230 | No comparison | 5 | SEC filing |
| Aug 6, 2018 | Initial | $10,000,000 | No comparison | 7 | SEC filing |
| Jun 9, 2017 | Initial | $12,000,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $599K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-493653
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Lake Street Capital Markets, LLC | 164447 |
Source: Form D, filed Oct 3, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Colpman | Director |
| Lode Debrabandere | Director, Executive |
| Matthew Ferguson | Executive |
| Jeffrey Hamet | Executive |
| William Hochberg | Director |
| Steven Hochberg | Director |
| Steven Hotchberg | Director |
| Maybelle Jordan | Director |
| Ronald Lloyd | Director, Executive |
| Brigid A. Makes | Director |
| C. Randal Mills | Director, Executive |
| Charles Randal Mills | Director |
| C. Randal Mills. Ph.D. | Director |
| Kevin Rakin | Director |
| Michelle Le Roux Williams | Executive |
| W. Matthew Zuga | Director |
| William Matthew Zuga | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12510 Prosperity Drive Suite 370
Silver Spring, MD, 20904
Silver Spring, MD, 20904